Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
reopro
janssen biologics b.v. - abciximab - abciximab
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
reopro injektionslösung
janssen-cilag ag - abciximabum - injektionslösung - abciximabum 2 mg, dinatrii phosphas dihydricus, natrii dihydrogenophosphas monohydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabilia q s. annuncio solutionem pro 1 ml. - perkutane koronarintervention - biotechnologika